|
Updated February 5, 2008
On June 8, 2006, the Federal Drug Administration approved a new vaccine to protect women from HPV, the leading cause of cervical cancer. While the announcement is good news for the public, it is most effective if given before a person is sexually active. In addition, even vaccinated women will still need to have a Pap test to screen for cervical cancer, as the vaccine does not protect against all types of HPV. Pathologists, physicians who study tissues and cells to identify cervical cancer and other diseases, recommend that the Pap test is still the most effective tool to detect cervical cancer.
If you would like to interview a CAP spokesperson about cervical cancer, HPV or Pap testing, please e-mail us at PublicAffairs@cap.org or call 800-323-4040 ext. 7538
In the media kit:
|
|
|
